BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 4275007)

  • 1. Inhibition of normal allogeneic responder cells in mouse mixed leukocyte culture by long-passage AKR leukemic lymphoblasts.
    Rodey GE; Sprader JC; Bortin MM
    Cancer Res; 1974 Jun; 34(6):1289-94. PubMed ID: 4275007
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific priming of mouse thymus-dependent lymphocytes to allogeneic cells in vitro.
    Andersson LC; Häyry P
    Eur J Immunol; 1973 Sep; 3(9):595-9. PubMed ID: 4271927
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged survival in long-passage AKR leukemia using chemotherapy, radiotherapy, and adoptive immunotherapy.
    Bortin MM; Rimm AA; Rodey GE; Giller R; Saltzstein EC
    Cancer Res; 1974 Aug; 34(8):1851-6. PubMed ID: 4152270
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term survival of mouse thymic lymphoid cells in vitro: effect of human serum.
    Ozato K
    J Immunol; 1973 Nov; 111(5):1459-69. PubMed ID: 4270393
    [No Abstract]   [Full Text] [Related]  

  • 6. Graft versus leukemia. 3. Apparent independent anthost and antileukemia activity of transplanted immunocompetent cells.
    Bortin MM; Rimm AA; Saltzstein EC; Rodey GE
    Transplantation; 1973 Sep; 16(3):182-8. PubMed ID: 4147030
    [No Abstract]   [Full Text] [Related]  

  • 7. Decline in mixed lymphocyte reactivity of spleen cells from aged mice of a long-lived strain.
    Konen TG; Smith GS; Walford RL
    J Immunol; 1973 May; 110(5):1216-21. PubMed ID: 4348973
    [No Abstract]   [Full Text] [Related]  

  • 8. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-T cell nature of the naturally occurring, spleen-associated suppressor cells present in the newborn mouse.
    Rodriguez G; Andersson G; Wigzell H; Peck AB
    Eur J Immunol; 1979 Sep; 9(9):737-46. PubMed ID: 159828
    [No Abstract]   [Full Text] [Related]  

  • 10. Thymus independent stimulator cells in the mixed lymphocyte reaction.
    Harrison MR
    J Immunol; 1973 Oct; 111(4):1270-3. PubMed ID: 4269624
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification and characterization of a soluble suppressor factor(s) in the serum of AKR mice bearing lymphocytic leukemia.
    Simon JD; Freed BM; Davignon D; Albala MM
    Cell Immunol; 1983 Nov; 82(1):163-73. PubMed ID: 6605807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ; Esparza AR; Albala MM
    Cancer Res; 1975 Mar; 35(3):637-9. PubMed ID: 234789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses in vitro. 3. Enhancement of the mouse mixed lymphocyte interaction by isologous and homologous sera.
    Peck AB; Click RE
    Eur J Immunol; 1973 Jul; 3(7):385-92. PubMed ID: 4271347
    [No Abstract]   [Full Text] [Related]  

  • 14. Syngeneic mixed lymphocyte reaction between thymocytes and peripheral lymphoid cells in mice: strain specificity and nature of the target cell.
    Von Boehmer H; Adams PB
    J Immunol; 1973 Feb; 110(2):376-83. PubMed ID: 4265142
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro reactivity of lymphoid cells from tolerant mice.
    Beverley PC; Brent L; Brooks C; Medawar PB; Simpson E
    Transplant Proc; 1973 Mar; 5(1):679-84. PubMed ID: 4266673
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross-reactivity exists between Mlsa and Mlsd lymphocyte-activating determinants as demonstrated by the negative clonal selection of responder cells in a mixed lymphocyte reaction.
    Ryan JJ; Ahmed A; Kind P; Sell KW
    Transplant Proc; 1979 Jun; 11(2):1377-8. PubMed ID: 157575
    [No Abstract]   [Full Text] [Related]  

  • 17. Leukemia induction in C3H mice following their inoculation with normal AKR lymphoid cells.
    Nemirovsky T; Trainin N
    Int J Cancer; 1973 Jan; 11(1):172-7. PubMed ID: 4151449
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitigation of graft-versus-host disease in mice by treatment of donors with bacterial endotoxin.
    Rose WC; Rodey GE; Rimm AA; Truitt RL; Bortin MM
    Exp Hematol; 1976 Mar; 4(2):90-6. PubMed ID: 4335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft versus leukemia. VIII. Selective reduction in antihost reactivity without loss of antileukemic reactivity by treatment of donor mice with lipopolysaccharide.
    Truitt RL; Rose WC; Rimm AA; Bortin MM
    Exp Hematol; 1978 May; 6(5):488-98. PubMed ID: 26584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Self-reactive" T cells. III. In vitro restimulation of T cells, "responding" in vivo or in vitro to syngeneic lymphoid cells.
    Reimann J; Diamantstein T
    Immunobiology; 1980 Dec; 157(4-5):463-73. PubMed ID: 6450160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.